Journal Article

Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

Kermani, Tanaz A, Mollan, Susan P, Cid, Maria C, Duftner, Christina, Kerschbaumer, Andreas, Smolen, Josef S, Abril, Andy, Appenzeller, Simone, Neill, Lorna, Hellmich, Bernhard, Aletaha, Daniel, Grayson, Peter C, Sattui, Sebastian Eduardo, Hysa, Elvis, Bond, Milena, Toro-Gutiérrez, Carlos Enrique, Seo, Philip, Ehlers, Lisa, Ponte, Cristina, Matteson, Eric L, Whitlock, Madeline, Schmidt, Wolfgang A, Camellino, Dario, Thiel, Jens, Buttgereit, Frank, Hočevar, Alojzija, Salvarani, Carlo, Dejaco, Christian, Dasgupta, Bhaskar

2024

Overview

ObjectivesTo develop treat-to-target (T2T) recommendations in giant cell arteritis (GCA) and polymyalgia rheumatica (PMR).MethodsA systematic literature review was conducted to retrieve data on treatment targets and outcomes in GCA/PMR as well as to identify the evidence for the effectiveness of a T2T-based management approach in these diseases. Based on evidence and expert opinion, the task force (29 participants from 10 countries consisting of physicians, a healthcare professional and a patient) developed recommendations, with consensus obtained through voting. The final level of agreement was provided anonymously.ResultsFive overarching principles and six-specific recommendations were formulated. Management of GCA and PMR should be based on shared decisions between patient and physician recognising the need for urgent treatment of GCA to avoid ischaemic complications, and it should aim at maximising health-related quality of life in both diseases. The treatment targets are achievement and maintenance of remission, as well as prevention of tissue ischaemia and vascular damage. Comorbidities need to be considered when assessing disease activity and selecting treatment.ConclusionThese are the first T2T recommendations for GCA and PMR. Treatment targets, as well as strategies to assess, achieve and maintain these targets have been defined. The research agenda highlights the gaps in evidence and the need for future research.

• Publisher: BMJ Publishing Group Ltd and European League Against Rheumatism,Elsevier Limited,BMJ Publishing Group
• Subject: Arteritis / Biological Therapy / Clinical medicine / Comorbidity / Giant Cell Arteritis / Giant Cell Arteritis - complications / Humans / Ischemia / Literature reviews / Outcome and Process Assessment, Health Care / Patients / Polymyalgia Rheumatica / Polymyalgia Rheumatica - epidemiology / Quality of Life / Recommendation / Remission / Remission (Medicine) / Rheumatology / Strategic management / Task forces / Vein & artery diseases